PCG
LXRX icon

Private Capital Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Private Capital Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-294
Closed -$1K – 2056
2020
Q2 		$1K Buy
+294
New +$576 ﹤0.01% 1849

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Private Capital Group's LXRX Position: Q3 2020 in Review

Private Capital Group sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2020, closing a stake of 294 shares — an estimated $1K sold.

Private Capital Group first reported a position in LXRX in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 91 funds tracked by Wall St. Rank hold LXRX as of Q3 2020.

  • Private Capital Group reported no remaining Lexicon Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Private Capital Group sold 294 Lexicon Pharmaceuticals shares in Q3 2020, an estimated $1K.
  • Private Capital Group first reported a position in Lexicon Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Private Capital Group's Lexicon Pharmaceuticals position peaked at $1K in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2020.

Based on Private Capital Group's 13F filing for Q3 2020, filed 12 Nov 2020.